Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion type Assertion NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_head.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion description "[The bcl-2 protein, however, was expressed by malignant cells of B and T cell lymphomas and by the giant tumour cells in 2/13 HD lymphocyte predominant, 11/28 HD nodular sclerosing I, 14/17 HD nodular sclerosing II, 10/27 HD mixed cellularity and 3/3 HD lymphocyte depleted.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_provenance.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion evidence source_evidence_literature NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_provenance.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion SIO_000772 7704322 NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_provenance.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion wasDerivedFrom befree-2016 NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_provenance.
- NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_assertion wasGeneratedBy ECO_0000203 NP1319007.RAc4rZoYnifhJf9AfR8dy6DdVw8MhFuNgSK7GFYhAg_Kw130_provenance.